JoVE Logo

Zaloguj się

Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.

W tym Artykule

  • Podsumowanie
  • Streszczenie
  • Protokół
  • Dyskusje
  • Ujawnienia
  • Podziękowania
  • Materiały
  • Odniesienia
  • Przedruki i uprawnienia

Podsumowanie

This video demonstrates the orthotopic aortic transplant model as a simple model to study the development of transplant vasculopathy (TVP) in rats.

Streszczenie

Research models of chronic rejection are essential to investigate pathobiological and pathophysiological processes during the development of transplant vasculopathy (TVP).

The commonly used animal model for cardiovascular chronic rejection studies is the heterotopic heart transplant model performed in laboratory rodents. This model is used widely in experiments since Ono and Lindsey (3) published their technique. To analyze the findings in the blood vessels, the heart has to be sectioned and all vessels have to be measured.

Another method to investigate chronic rejection in cardiovascular questionings is the aortic transplant model (1, 2). In the orthotopic aortic transplant model, the aorta can easily be histologically evaluated (2). The PVG-to-ACI model is especially useful for CAV studies, since acute vascular rejection is not a major confounding factor and Cyclosporin A (CsA) treatment does not prevent the development of CAV, similar to what we find in the clinical setting (4). A7-day period of CsA is required in this model to prevent acute rejection and to achieve long-term survival with the development of TVP.

This model can also be used to investigate acute cellular rejection and media necrosis in xenogeneic models (5).

Protokół

Rats weighing approximately 250-300g are purchased from Charles River (Sandhofer Weg 7, D-97633 Sulzfeld).
Transplants are performed using PVG rats as donors, and ACI rats as recipients.

Rats are housed under conventional conditions, fed standard rat chow and water ad libidum.

All surgical instruments are sterilized prior to use.

Donor preparation:

Anesthetize rat with isoflurane (2,5-3%) using an induction chamber.

  1. Shave the abdominal and thoracic hair and place the rat on its back and place a facemask over its nose and mouth to keep up the anesthesia.
  2. Disinfect the abdominal and thoracic area widely using Provo-Iodine, next use 80% ethanol, repeat this step three times.
  3. Check reflexes pinching the hind feet to be sure that the rat is sufficient anesthesized.
  4. Exsanguinate the rat by opening the abdomen and cutting a hole into the abdominal aorta.
  5. Carefully open the thorax to find the descending thoracic aorta.
  6. Dissect the thoracic aorta from surrounding tissues like fat, nerves and the oesophagus.
  7. Withdraw a 1.5cm piece of the aorta using a couter, without tissue damage of the aorta.
  8. Perfuse the aortic graft throughly with cold sterile saline and store the graft at 4°C.

Recipient:

Anesthetize rat with isoflurane (2,5-3%) using an induction chamber. Body temperature is maintained during the surgical procedure.

  1. Shave abdominal area and apply eye ointment to prevent the eyes from drying during anesthesia.
  2. Place the rat on its back and place a facemask over its nose and mouth to keep up the anesthesia.
  3. Disinfect the abdominal area using Provo-Iodine, next use 80% ethanol, repeat this step three times.
  4. Check reflexes pinching the hind feet to be sure that the rat is sufficient anesthesized.
  5. Perform a midline abdominal incision separating the skin and muscle in two steps to open the abdomen.
  6. Place the intestines in a warmed saline moisturized powder free glove. Fold the glove around the intestines to prevent loss of moisture.
  7. Remove the fatty tissue covering the abdominal aorta.
  8. Dissect the aorta form the infrarenal region to the bifurcation, careful not to cause damage on the branches of the vessels.
  9. If necessary ligate branches of the aorta.
  10. First use a microsurgical clamp on the infrarenal part of the dissected aorta to stop the blood flow.
  11. Next, place a second clamp close to the bifurcation of the aorta.
  12. Now that the blood flow is stopped, remove a short segment of the aorta.
  13. Take the donor aortic graft, that has been kept in 0,9% sterile saline on ice, shorten it to the adequate length and position it in the gap.
  14. Connect the donor aorta to the recipient aorta, performing running sutures using 8-0 prolene suture (Ethicon, Norderstedt, Germany). Start with the cranial end-to-end anastomosis.
  15. When the distal end-to-end anastomosis is finished, carefully open the distal clamp.
  16. When there is no bleeding after opening the distal clamp, carefully open the cranial clamp. In case of bleeding at the sutures, close the clamp again, locate the bleeding and stop the bleeding using one single stitch.
  17. There should be a visible pulse at the distal end of the aorta.
  18. Next move the intestines back into the abdomen.
  19. Flush the abdomen with prewarmed sterile saline.
  20. Close the muscle layer of the abdominal wall using 6-0 prolene running sutures (Ethicon, Norderstedt, Germany).
  21. Use 5-0 prolene (Ethicon, Norderstedt, Germany) running sutures to close the skin.
  22. While the rat is still in anesthesia, inject 4-5mg/kg Carprofen subcutaneously.
  23. To provide sufficient analgesia for this type of procedure, metamizol is added to the drinking water (50mg Metamizol per 100ml) for pain medication for 3 days post transplantation.

Dyskusje

For several reasons we found the orthotopic aortic transplantation model a more accurate way to investigate the development of TVP compared to the heterotopic heart transplantation model:
Regarding the surgical technique, the aortic transplant model embodies an easily feasible method, requiring solely the accomplishment of end-to-end-anastomosis, whereas the heterotopic heart transplant model may be considered a more complex and error-prone challenge to the surgeon s skills, requiring end-to-side anastomosis on tw...

Ujawnienia

No conflicts of interest declared.

Podziękowania

The authors thank Christiane Pahrmann for her histological work.

Funding

Sonja Schrepfer has received a research grant from the Deutsche Forschungsgemeinschaft (DFG) (SCHR992/3 1 and SCHR992/4-1).]

Materiały

NameCompanyCatalog NumberComments
Surgical microscope (magnification 25x)
Isoflurane
shaver
Provo-Iodine
ice cold 0.9% saline
prewarmed 0.9% sterile saleine
eye ointment
glove
microsurgical scissirs
forceps
clamps
8-0 suture (prolene)
6-0 suture (prolene)
5-0 suture (prolene)
Carprofen
Metamizol
Q-tips

Odniesienia

  1. Deuse, T., Hoyt, G., Koyanagi, T., Robbins, R. C., Schrepfer, S. Prevention and Inhibition But Not Reversion of Chronic Allograft Vasculopathy by FK778. Transplantation. 85, 870-877 (2008).
  2. Mennander, A., Tiisala, S., Halttunen, J., Yilmaz, S., Paavonen, T., Hayry, P. Chronic rejection in rat allografts. An experimental model for transplant arteriosclerosis. Arterioscler Thromb Vasc Biol. 11, 671-680 (1991).
  3. Ono, K., Lindsey, E. S. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg. 57, 225-225 (1969).
  4. Poston, R. S., Billingham, M., Hoyt, E. G. Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model. Circulation. 100, 67-100 (1999).
  5. Schrepfer, S., Deuse, T., Koch-Nolte, F., Krieger, T., Haddad, M., Schäfer, H., Pelletier, M. P., Robbins, R. C., Reichenspurner, H. FK778 in Experimental Xenotransplantation: A Detailed Analysis of Drug Efficacy. J Heart Lung Transplant. 26, 70-77 (2007).

Przedruki i uprawnienia

Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE

Zapytaj o uprawnienia

Przeglądaj więcej artyków

Orthotopic Aortic TransplantationRat ModelChronic VasculopathyTransplant VasculopathyHeterotopic Heart Transplant ModelLaboratory RodentsAortic Transplant ModelHistological EvaluationPVG to ACI ModelCyclosporin A TreatmentAcute Cellular RejectionMedia NecrosisXenogeneic Models

This article has been published

Video Coming Soon

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone